Prenosis, Inc.
CHAMPAIGN, IL · Founded 2014 · CIK 0001668485 · Medtech · Private
Immunix platform: AI-driven clinical decision support system that integrates biomarker assays (43 protein markers), clinical data from EMRs, and machine learning to classify patient endotypes and guid
prenosis.com →- Grants
- $11M
- 12 awards
- Sector median: 1
- Raised
- $1.6M
- 2 Form D · Sep 2016
- 121 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 23
- 1 granted · 22 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520172019202120232025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $65,000 | |
| Private capital raised | Form D · SEC | $1,500,030 | |
| Federal grant | National Science Foundation · Phase I · SBIR Phase I: Point of Care Device for High Frequency Stratification of Patient Populations at Risk of Sepsis | $150,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Point of Care Device for Reducing Overuse of Antibiotics in Potentially Septic Hospital Populations | $150,000 | |
| Federal grant | National Science Foundation · Phase II · SBIR Phase II: Point of Care Device for High Frequency Stratification of Patient Populations at Risk of Sepsis | $704,525 | |
| Federal grant | Department of Health and Human Services · Phase II · Collaborative Platform for Developing Sepsis Products by Leveraging Sepsis Endotypes Developed Using a Unified Biomarker-Clinical Dataset | $989,523 | |
| Federal grant | Department of Health and Human Services · Phase II · Collaborative Platform for Developing Sepsis Products by Leveraging Sepsis Endotypes Developed Using a Unified Biomarker-Clinical Dataset | $989,522 | |
| Federal grant | Department of Health and Human Services · Phase II · Use of Time Series Biomarker and Clinical Data to Construct a Time Trajectory Host Response Map | $1,272,176 | |
| Federal grant | Department of Health and Human Services · Phase II · Combined Biomarker and EMR Data for Heterogeneous Treatment Effects and Surrogate Endpoints in Sepsis | $1,161,624 | |
| Federal grant | Department of Health and Human Services · Phase II · Use of Time Series Biomarker and Clinical Data to Construct a Time Trajectory Host Response Map | $1,272,176 | |
| Federal grant | Department of Health and Human Services · Phase II · Combined Biomarker and EMR Data for Heterogeneous Treatment Effects and Surrogate Endpoints in Sepsis | $1,161,624 | |
| Federal grant | Department of Health and Human Services · Phase II · Use of Time Series Biomarker and Clinical Data to Construct a Time Trajectory Host Response Map | $1,272,176 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical Validation of a Point-of-Care Precision Medicine Endotyping Platform | $700,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Clinical Validation of a Point-of-Care Precision Medicine Endotyping Platform | $700,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 804 | AVEERA MEDICAL INC. | — | $8.8M |
| 805 | NANOCAN THERAPEUTICS CORPORATION | — | $6.2M |
| 806 | XCath, Inc. | — | $5.3M |
| 807 | Prenosis, Inc. | — | $1.6M |
| 808 | Fresenius Medical Care Winter Lake, LLC | — | $3.6M |
| 809 | SISCAPA Assay Technologies, Inc. | — | $3.6M |
| 810 | Kerecis hf | — | $3.5M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Rashid BashirDirector · Executive Officer
- Gary DurackExecutive Officer
- Bobby ReddyDirector · Executive Officer
Patents
- Systems And Methods For Normalization Of Machine Learning Datasetsapplication
- Systems And Methods For Generating An Interactive Patient Dashboardapplication
- Systems And Methods For Adaptative Training Of Machine Learning Modelsapplication
- A Time-sensitive Trigger For A Streaming Data Environmentapplication
- A Tool For Selecting Relevant Features In Precision Diagnosticsapplication
- Microfluidic Cartridge And Stacked Testing Assembly With Microfluidic Cartridge Thereofgranted
- Methods And Systems For Medical Condition Risk Prediction And Prediction Triggeringapplication
- Methods And Systems For Medical Condition Risk Prediction And Prediction Triggeringapplication
- Systems And Methods Of Artificial Intelligence-based Sepis Predictionapplication
- Systems And Methods For Generating An Interactive Patient Dashboardapplication
- Systems And Methods For Adaptative Training Of Machine Learning Modelsapplication
- Systems And Methods For Normalization Of Machine Learning Datasetsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.